NewEdge Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9M Buy
29,269
+7,289
+33% +$2.96M 0.06% 327
2025
Q1
$10.9M Sell
21,980
-8,509
-28% -$4.23M 0.07% 298
2024
Q4
$15.9M Buy
30,489
+843
+3% +$439K 0.1% 209
2024
Q3
$18.3M Buy
29,646
+4,950
+20% +$3.06M 0.12% 183
2024
Q2
$13.7M Buy
24,696
+1,784
+8% +$987K 0.1% 205
2024
Q1
$13.3M Buy
22,912
+3,824
+20% +$2.22M 0.12% 185
2023
Q4
$10.2M Buy
19,088
+2,066
+12% +$1.11M 0.1% 207
2023
Q3
$8.62M Buy
17,022
+1,333
+8% +$675K 0.09% 212
2023
Q2
$8.19M Sell
15,689
-834
-5% -$435K 0.09% 221
2023
Q1
$9.47M Sell
16,523
-416
-2% -$238K 0.12% 182
2022
Q4
$5.46M Buy
16,939
+2,582
+18% +$832K 0.15% 146
2022
Q3
$7.28M Buy
14,357
+1,526
+12% +$774K 0.12% 183
2022
Q2
$6.97M Buy
12,831
+1,031
+9% +$560K 0.12% 181
2022
Q1
$6.97M Sell
11,800
-194
-2% -$115K 0.11% 180
2021
Q4
$8M Buy
11,994
+5,186
+76% +$3.46M 0.12% 167
2021
Q3
$3.89M Buy
6,808
+1,758
+35% +$1M 0.1% 202
2021
Q2
$2.5M Buy
5,050
+457
+10% +$226K 0.07% 267
2021
Q1
$2.1M Buy
4,593
+85
+2% +$38.8K 0.06% 273
2020
Q4
$2.1M Sell
4,508
-3,294
-42% -$1.53M 0.07% 247
2020
Q3
$3.45M Buy
7,802
+733
+10% +$324K 0.12% 174
2020
Q2
$2.56M Buy
7,069
+851
+14% +$308K 0.1% 196
2020
Q1
$1.76M Buy
6,218
+4,235
+214% +$1.2M 0.09% 216
2019
Q4
$644K Sell
1,983
-206
-9% -$66.9K 0.03% 455
2019
Q3
$626K Buy
2,189
+1,208
+123% +$345K 0.03% 434
2019
Q2
$288K Buy
981
+109
+13% +$32K 0.02% 535
2019
Q1
$239K Buy
+872
New +$239K 0.02% 587
2018
Q4
Sell
-1,527
Closed -$373K 712
2018
Q3
$373K Buy
1,527
+137
+10% +$33.5K 0.03% 439
2018
Q2
$286 Sell
1,390
-44
-3% -$9 0.03% 422
2018
Q1
$291K Buy
1,434
+145
+11% +$29.4K 0.03% 358
2017
Q4
$261K Sell
1,289
-386
-23% -$78.2K 0.04% 345
2017
Q3
$324K Buy
1,675
+1,351
+417% +$261K 0.05% 270
2017
Q2
$57.6K Buy
+324
New +$57.6K 0.01% 508